Chabiotech Co.,Ltd. (KOSDAQ:085660)
South Korea · Delayed Price · Currency is KRW 18,950
+200 (1.07%)
Mar 20, 2026, 3:30 PM KST
Chabiotech Market Cap
Chabiotech has a market cap or net worth of 1.74 trillion as of March 20, 2026. Its market cap has increased by 156.44% in one year.
Market Cap
1.74T
Enterprise Value
2.68T
Revenue
1.20T
Ranking
n/a
PE Ratio
n/a
Stock Price
18,950.00
Market Cap Chart
Since February 23, 2009, Chabiotech's market cap has increased from 334.13B to 1.74T, an increase of 421.51%. That is a compound annual growth rate of 10.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 1.74T | 55.67% |
| Dec 30, 2025 | 1.12T | 74.51% |
| Dec 30, 2024 | 641.46B | -41.85% |
| Dec 28, 2023 | 1.10T | 50.82% |
| Dec 29, 2022 | 731.49B | -34.83% |
| Dec 30, 2021 | 1.12T | 6.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OliX Pharmaceuticals | 3.67T |
| D&D Pharmatech | 3.43T |
| PharmaResearch | 3.33T |
| SK bioscience | 3.29T |
| Hugel | 2.83T |
| Orum Therapeutics | 2.75T |
| Onconic Therapeutics | 1.13T |
| Pharmicell | 955.86B |